These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30642238)

  • 1. Novel Data on the Prevalence, Identification, Scouting, and Treatment of Familial Hypercholesterolaemia.
    Doumas M; Imprialos K; Stavropoulos K; Athyros VG
    Curr Pharm Des; 2018; 24(31):3597-3598. PubMed ID: 30642238
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial hypercholesterolaemia: different perspectives.
    Jones JL; Lakasing E; Archontakis S
    Nurs Stand; 2009 Aug 19-25; 23(50):35-8. PubMed ID: 19736707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia.
    Viigimaa M; Heinsar S; Lovic D; Katsimardou A; Piperidou A; Duishvili D
    Curr Pharm Des; 2018; 24(31):3599-3604. PubMed ID: 30306860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia.
    Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G
    Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834
    [No Abstract]   [Full Text] [Related]  

  • 5. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
    Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
    Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of low-density lipoprotein receptor expression in receptor defective homozygous familial hypercholesterolemia by inhibition of PCSK9 with alirocumab.
    Lambert G; Chatelais M; Petrides F; Passard M; Thedrez A; Rye KA; Schwahn U; Gusarova V; Blom DJ; Sasiela W; Marais AD
    J Am Coll Cardiol; 2014 Dec; 64(21):2299-300. PubMed ID: 25456764
    [No Abstract]   [Full Text] [Related]  

  • 8. Multimodal Treatment of Homozygous Familial Hypercholesterolemia.
    Gossios T; Zografou I; Simoulidou V; Pirpassopoulou A; Christou K; Karagiannis A
    Curr Pharm Des; 2018; 24(31):3616-3621. PubMed ID: 30306858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 10. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational therapy of familial hypercholesterolemia.
    Reynolds GA
    Circulation; 1989 May; 79(5):1146-8. PubMed ID: 2496938
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
    Leitersdorf E; Eisenberg S; Eliav O; Friedlander Y; Berkman N; Dann EJ; Landsberger D; Sehayek E; Meiner V; Wurm M
    Circulation; 1993 Apr; 87(4 Suppl):III35-44. PubMed ID: 8462179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boy with autosomal recessive hypercholesterolaemia.
    Rodenburg J; Wiegman A; Vissers MN; Kastelein JJ; Stalenhoef AF
    Neth J Med; 2004 Mar; 62(3):89-93. PubMed ID: 15209474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 17. An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statin.
    Ohshiro T; Mabuchi H; Ohta T
    J Atheroscler Thromb; 2010 Oct; 17(10):1113. PubMed ID: 20962452
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.
    Couture P; Brun LD; Szots F; Lelièvre M; Gaudet D; Després JP; Simard J; Lupien PJ; Gagné C
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1007-12. PubMed ID: 9633944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background.
    Choumerianou DM; Dedoussis GV
    Clin Chem Lab Med; 2005; 43(8):793-801. PubMed ID: 16201887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A keen eye for risk.
    Ford TJ; Rocchiccioli P
    BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.